Age-related macular degeneration and mortality in community-dwelling elders: The age, gene/environment susceptibility reykjavik study

Ophthalmology

Volumn 122, Issue 2, 2015, Pages 382-390

  Fisher, Diana E ^a   Jonasson, Fridbert ^b,c   Eiriksdottir, Gudny ^d   Sigurdsson, Sigurdur ^d   Klein, Ronald ^e   Launer, Lenore J ^f   Gudnason, Vilmundur ^c,d   Cotch, Mary Frances ^a  

^a NATIONAL EYE INSTITUTE   (United States)

^b LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^c UNIVERSITY OF ICELAND   (Iceland)

^d ICELANDIC HEART ASSOCIATION   (Iceland)

^e UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^f NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGE RELATED MACULAR DEGENERATION; AGED; AGING; ARTICLE; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; COHORT ANALYSIS; COMMUNITY; COMMUNITY DWELLING ELDER; EYE FUNDUS; FEMALE; GERIATRIC PATIENT; HUMAN; ICELAND; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; POPULATION RESEARCH; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; VERY ELDERLY; AGE; DISEASE PREDISPOSITION; EPIDEMIOLOGY; FOLLOW UP; GENOTYPE ENVIRONMENT INTERACTION; INCIDENCE; MACULAR DEGENERATION; RISK FACTOR;

AGE FACTORS; AGED; AGED, 80 AND OVER; CAUSE OF DEATH; COHORT STUDIES; DISEASE SUSCEPTIBILITY; FEMALE; FOLLOW-UP STUDIES; GENE-ENVIRONMENT INTERACTION; HUMANS; ICELAND; INCIDENCE; MACULAR DEGENERATION; MALE; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 84921477132     PISSN: 01616420     EISSN: 15494713     Source Type: Journal    
DOI: 10.1016/j.ophtha.2014.08.006     Document Type: Article

References (30)

1. J.M. Seddon, W.C. Willett, F.E. Speizer, and S.E. Hankinson A prospective study of cigarette smoking and age-related macular degeneration in women JAMA 276 1996 1141 1146
2. J.M. Seddon, J. Cote, N. Davis, and B. Rosner Progression of age-related macular degeneration: association with body mass index, wrist circumference, and waist-hip ratio Arch Ophthalmol 121 2003 785 792
3. Eye Disease Case-Control Study Group Risk factors for neovascular age-related macular degeneration Arch Ophthalmol 110 1992 1701 1708
4. J.R. Vingerling, I. Dielemans, and M.L. Bots Age-related macular degeneration is associated with atherosclerosis. The Rotterdam Study Am J Epidemiol 142 1995 404 409
5. L. Hyman, A.P. Schachat, Q. He, and M.C. Leske Age-Related Macular Degeneration Risk Factors Study Group. Hypertension, cardiovascular disease, and age-related macular degeneration Arch Ophthalmol 118 2000 351 358
6. W. Smith, P. Mitchell, S.R. Leeder, and J.J. Wang Plasma fibrinogen levels, other cardiovascular risk factors, and age-related maculopathy: the Blue Mountain Eye Study Arch Ophthalmol 116 1998 583 587
7. R. Klein, B.E. Klein, and T. Franke The association of cardiovascular disease and its risk factors to age-related maculopathy: the Beaver Dam Eye Study Ophthalmology 100 1993 406 414
8. C.A. McCarty, B.N. Mukesh, and C.L. Fu Risk factors for age-related maculopathy: the Visual Impairment Project Arch Ophthalmol 119 2001 1455 1462
9. H. Buch, T. Vinding, and M. la Cour Age-related maculopathy: a risk indicator for poorer survival in women: the Copenhagen City Eye Study Ophthalmology 112 2005 305 312
10. T.Y. Wong, G. Tikellis, and C. Sun Age-related macular degeneration and risk of coronary heart disease: the Atherosclerosis Risk in Communities Study Ophthalmology 114 2007 86 91
11. L. Xu, Y.X. Wang, J. Wang, and J.J. Jonas Mortality and ocular diseases: the Beijing Eye Study Ophthalmology 116 2009 732 738
12. S. Cugati, R.G. Cumming, and W. Smith Visual impairment, age-related macular degeneration, cataract, and long-term mortality: the Blue Mountains Eye Study Arch Ophthalmol 125 2007 917 924
13. J.S. Tan, J.J. Wang, and G. Liew Age-related macular degeneration and mortality from cardiovascular disease or stroke Br J Ophthalmol 92 2008 509 512
14. R.E. Gangnon, K.E. Lee, and B.E. Klein Effect of the Y402H variant in the complement factor H gene on the incidence and progression of age-related macular degeneration: results from multistate models applied to the Beaver Dam Eye Study Arch Ophthalmol 130 2012 1169 1176
15. M. Knudtson, B.E. Klein, and R. Klein Age-related eye disease, visual impairment, and survival: the Beaver Dam Eye Study Arch Ophthalmol 124 2006 243 249
16. P.H. Borger, R. van Leeuwen, and C.A. Hulsman Is there a direct association between age-related eye diseases and mortality? The Rotterdam Study Ophthalmology 110 2003 1292 1296
17. R. Klein, B.E. Klein, and S.E. Moss Age-related eye disease and survival: the Beaver Dam Eye Study Arch Ophthalmol 113 1995 333 339
18. M. Thiagarajan, J.R. Evans, and L. Smeeth Cause-specific visual impairment and mortality: results from a population-based study of older people in the United Kingdom Arch Ophthalmol 123 2005 1397 1403
19. AREDS Research Group Associations of mortality with ocular disorders and an intervention of high-dose antioxidants and zinc in the Age-Related Eye Disease Study: AREDS report no. 13 Arch Ophthalmol 122 2004 716 726
20. F. Jonasson, A. Arnarsson, and G. Eiríksdottir Prevalence of age-related macular degeneration in old persons: Age, Gene/Environment Susceptibility Reykjavik Study Ophthalmology 118 2011 825 830
21. F. Jonasson, D.E. Fisher, and G. Eiriksdottir Five-year incidence, progression and risk factors for age-related macular degeneration: the Age, Gene/Environment Susceptibility Study Ophthalmology 121 2014 1766 1772
22. T.B. Harris, L.J. Launer, and G. Eiriksdottir Age, Gene/Environment Susceptibility-Reykjavik Study: multidisciplinary applied phenomics Am J Epidemiol 165 2007 1076 1087
23. R. Klein, M.D. Davis, and Y.L. Magli The Wisconsin Age-Related Maculopathy Grading System Ophthalmology 98 1991 1128 1134
24. R. Klein, S.M. Meuer, and S.E. Moss Detection of age-related macular degeneration using a nonmydriatic digital camera and a standard film fundus camera Arch Ophthalmol 122 2004 1642 1646
25. R. Klein, B.E. Klein, and M.D. Knudtson Prevalence of age-related macular degeneration in 4 racial/ethnic groups in the Multi-ethnic Study of Atherosclerosis Ophthalmology 113 2006 373 380
26. R.M. Conroy, K. Pyorala, A.P. Fitzgerald SCORE Project Group Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project Eur Heart J 24 2003 987 1003
27. J.S. Saczynski, M.K. Jonsdottir, and M.E. Garcia Cognitive impairment: an increasingly important complication of type 2 diabetes. The Age, Gene/Environment Susceptibility-Reykjavik Study Am J Epidemiol 168 2008 1132 1139
28. M.K. Adams, J.A. Simpson, and A.J. Richardson Can genetic associations change with age? CFH and age-related macular degeneration Hum Mol Genet 21 2012 5229 5236
29. J. Jylhava, C. Eklund, and M. Jylha Complement factor H 402His variant confers an increased mortality risk in Finnish nonagenarians: the Vitality 90+ Study Exp Gerontol 44 2009 297 299
30. D. Fisher, C. Li, and M. Chiu Impairments in hearing and vision impact on mortality in older persons: the AGES-Reykjavik Study Age Ageing 43 2014 69 76